MedTrace Logo

Acarbose and Older Adults With Postprandial Hypotension

NCT01914133 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2021-05-28

No results posted yet for this study

Summary

The current proposal will determine if blocking carbohydrate intake in the small intestine with Acarbose can be a possible therapy for older adults with (PPH) Post Prandial Hypotension (a drop of blood pressure after eating), which can result in falls.

Conditions

  • Other Specified Hypotension
  • Syncope

Interventions

DRUG

Acarbose

Acarbose 50 mg given during Meal Test and Acarbose 25 mg taken with first bite of the next 3 meals.

DRUG

Placebo

Placebo given prior to meal the standardized meal

Sponsors & Collaborators

  • Kenneth Madden

    lead OTHER

Principal Investigators

  • Kenneth M Madden, MD · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2021-05-31
Completion
2021-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01914133 on ClinicalTrials.gov